The effect of ambroxol, a bronchial mucolytic agent, on gastric mucus was investigated in man.
Ten patients with bronchial hypersecretion were treated with ambroxol 30 mg t.i.d. by the oral route for 10 days. Before and after treatment the amount of total mucoproteins in the gastric juice was measured and a ‘mucoprotective index’ was calculated. Neither quantitative nor qualitative changes in gastric mucus were observed after ambroxol treatment. Our results show that the drug does not exert lytic effects on the gastric mucus layer and hence is devoid of damaging activity on the gastric mucosa.
Get full access to this article
View all access options for this article.
References
1.
GlassG B J (1967) Current status of the mucoprotein and mucoproteose fractions of the gastric mucin: a review of 15 years' progress in this area. Annals of the New York Academy of Sciences140, 804.
2.
GlassG B JSlomianyB L (1977) Derangements of biosynthesis, production and secretion of mucus in gastrointestinal injury and disease. In: Mucus in Health and Disease (ElsteinMParkeD V, eds). Plenum Press, New York. p 311.
3.
GrassiCLuisettiMDe RoseVFiettaASacchiFGenghiniMPozziE (1983) Biomedical and functional changes in broncho-alveolar parameters induced by ambroxol treatment of chronic bronchitis. In: Pulmonary Surfactant System (CosmiE VScarpelliE M, eds). ElsevierAmsterdam. p 361.
4.
GuslandiM (1982) Mucolytics and the stomach. Pharmacy International7, 228.
5.
GuslandiM (1983) Evaluation of gastric mucus in man by means of the ‘mucoprotective index’: a review of a five-year experience with this method. Methods and Findings in Experimental and Clinical Pharmacology5, 735.
6.
GuslandiMBallarinETittobelloA (1981) Gastric mucus secretion in ranitidine-treated patients. British Medical Journal283, 699.
7.
GuslandiMMasciETestoniP ATittobelloA (1984) The viscosity of mucus depends on its neutral mucoprotein content. Proceedings XII International Congress of Gastroenterology, Lisbon 1984, no 24.
8.
JivraiMMarriotCMartinG PTurnerN C (1984) The effect of potential ulcerogenic agents on hydrogen ion diffusion through native porcine gastric mucus. Journal of Physiology354, 85.
9.
MarriottCBrownD TBeesonM F (1982) Evaluation of mucolytic activity using a purified mucus glycoprotein gel. In: Mucus in Health and Disease, Vol. II (ChantlerE NElderJ BElsteinM, eds). Plenum Press, New York. p 93.
10.
McQeenSHuttonDAllenAGarnerA (1983) Gastric and duodenal surface mucus gel thickness: effects of prostaglandins and damaging agents. American Journal of Physiology245, G388.
11.
MillerT A (1983) Protective effects of prostaglandins against mucosal damage: current knowledge and proposed mechanisms. American Journal of Physiology245, G601.
12.
ReesW D WTurnbergL A (1982) Mechanisms of gastric mucosal protection: a role for the ‘mucus-bicarbonate’ barrier. Clinical Science62, 343.
13.
RenschTRenovanzH D (1978) Sputumviskosimetrie unter Berucksichtingung eines neu entwickelten Viskosimeters. In: Fortbildung in Thoraxkrankheiten, Vol. 8. Hippokrates Verlag, Stuttgart. p 100.
14.
RossI NBahariH M MTurnbergL A (1981) The pH gradient across mucus adherent to rat fundic mucosa in vivo and the effects of potential damaging agents. Gastroenterology81, 713.
15.
ZlotoffR ALakeA MHamiltonS RHendrixT R (1982) N-acetylcystein attenuates the cytoprotective effect of topical PGE2 in rat stomach. Gastroenterology82, 1218.
